Merger Arbitrage Tool – InsideArbitrage

Filter by Deal Type:

Note: Premium members can sort this table by Return, Annualized Return and Estimated Closing Date.

	Target	Announced Date	Acquirer	Deal Type	Closing Value	Deal Price	Last Price	Target Volume	Options	Div. Yield	Estimated Closing Date	Return	Annualized Return
	TMX chart	12/14/21	Rentokil Initial plc (RTOKY)	Special Conditions	$6.7 B	$55.00	$41.91	721,666	Yes	N/A	9/30/22	31.23%	85.08%
The following funds have a position in Terminix Global Holdings, Inc.: 1. Gabelli Funds LLC 2. Magnetar Financial LLC 3. P Schoenfeld Asset Management LP 4. TIG Advisors, LLC 5. Tudor Investment Corp ET AL Terminix Global Holdings, Inc. merger details: Expected to close in the second half of 2022 for a closing value of $6.7 billion in a cash or stock deal. Under the terms of the agreement, Under the terms of the Agreement, Rentokil Initial will issue to Terminix shareholders at closing aggregate consideration comprised of approximately 643.29 million new Rentokil Initial shares (representing approximately 128.66 million American depository shares (“ADSs”), based on a 1:5 ADS to Rentokil Initial share ratio) and approximately US$1.3bn in cash. Based on Rentokil Initial’s 5-day average daily volume weighted share price and the 5-day average of the Sterling-US Dollar exchange rate both over the period spanning 6 to 10 December 2021 inclusive, this values the entire share capital of Terminix at US$6.7 billion, implying a value of US$55.00 per share of Terminix common stock, and represents an aggregate consideration mix of 80% stock and 20% cash. Terminix shareholders may elect to receive all cash or all stock consideration, subject to proration in the event of oversubscription. Each Terminix share for which no election or an invalid election is received will be deemed to have elected for all stock consideration. The value of the per share cash election and the value of the per share stock election will be equalised ahead of closing such that the value of each election choice will be substantially the same. Merger Agreement Terminix Global Holdings, Inc. Investor Relations Rentokil Initial Investor Relations Termination Payment: Company Termination Payment (To be paid by Terminix Global Holdings): $200 million Parent Termination Payment (To be paid by Rentokil Initial): $150 million Update(s) March 15, 2022: Rentokil Initial and Terminix (TMX) announced that with effect from the close of business on 14 March 2022, the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 has now expired. May 9, 2022: Terminix Global Holdings (TMX) announced it has entered into a definitive agreement to divest its pest management businesses in the U.K. and Norway. These businesses are being divested by Terminix as a condition to the closing of its pending merger with Rentokil Initial (RTOKY).

Target

Acquirer

Deal
Type

Closing
Value

Deal
Price

Last
Price

Target
Volume

Options

Div. Yield

TMX chart

12/14/21

Rentokil Initial plc (RTOKY)

Special Conditions

$6.7 B

$55.00

$41.91

721,666

Yes

N/A

9/30/22

31.23%

85.08%

The following funds have a position in Terminix Global Holdings, Inc.:
1. Gabelli Funds LLC
2. Magnetar Financial LLC
3. P Schoenfeld Asset Management LP
4. TIG Advisors, LLC
5. Tudor Investment Corp ET AL

Terminix Global Holdings, Inc. merger details:

Expected to close in the second half of 2022 for a closing value of $6.7 billion in a cash or stock deal. Under the terms of the agreement, Under the terms of the Agreement, Rentokil Initial will issue to Terminix shareholders at closing aggregate consideration comprised of approximately 643.29 million new Rentokil Initial shares (representing approximately 128.66 million American depository shares (“ADSs”), based on a 1:5 ADS to Rentokil Initial share ratio) and approximately US$1.3bn in cash. Based on Rentokil Initial’s 5-day average daily volume weighted share price and the 5-day average of the Sterling-US Dollar exchange rate both over the period spanning 6 to 10 December 2021 inclusive, this values the entire share capital of Terminix at US$6.7 billion, implying a value of US$55.00 per share of Terminix common stock, and represents an aggregate consideration mix of 80% stock and 20% cash. Terminix shareholders may elect to receive all cash or all stock consideration, subject to proration in the event of oversubscription. Each Terminix share for which no election or an invalid election is received will be deemed to have elected for all stock consideration. The value of the per share cash election and the value of the per share stock election will be equalised ahead of closing such that the value of each election choice will be substantially the same.

Merger Agreement

Terminix Global Holdings, Inc. Investor Relations

Rentokil Initial Investor Relations

Termination Payment:

Company Termination Payment (To be paid by Terminix Global Holdings): $200 million

Parent Termination Payment (To be paid by Rentokil Initial): $150 million

Update(s)

March 15, 2022: Rentokil Initial and Terminix (TMX) announced that with effect from the close of business on 14 March 2022, the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 has now expired.

May 9, 2022: Terminix Global Holdings (TMX) announced it has entered into a definitive agreement to divest its pest management businesses in the U.K. and Norway. These businesses are being divested by Terminix as a condition to the closing of its pending merger with Rentokil Initial (RTOKY).

Note: Premium members can sort this table by Target, Return, Annualized Return and Estimated Closing Date. Desktop Version

	Target	Estimated Closing Date	Return	Annualized Return
	TMX chart	9/30/22	31.23%	85.08%
The following funds have a position in Terminix Global Holdings, Inc.: 1. Gabelli Funds LLC 2. Magnetar Financial LLC 3. P Schoenfeld Asset Management LP 4. TIG Advisors, LLC 5. Tudor Investment Corp ET AL Terminix Global Holdings, Inc. merger details: Expected to close in the second half of 2022 for a closing value of $6.7 billion in a cash or stock deal. Under the terms of the agreement, Under the terms of the Agreement, Rentokil Initial will issue to Terminix shareholders at closing aggregate consideration comprised of approximately 643.29 million new Rentokil Initial shares (representing approximately 128.66 million American depository shares (“ADSs”), based on a 1:5 ADS to Rentokil Initial share ratio) and approximately US$1.3bn in cash. Based on Rentokil Initial’s 5-day average daily volume weighted share price and the 5-day average of the Sterling-US Dollar exchange rate both over the period spanning 6 to 10 December 2021 inclusive, this values the entire share capital of Terminix at US$6.7 billion, implying a value of US$55.00 per share of Terminix common stock, and represents an aggregate consideration mix of 80% stock and 20% cash. Terminix shareholders may elect to receive all cash or all stock consideration, subject to proration in the event of oversubscription. Each Terminix share for which no election or an invalid election is received will be deemed to have elected for all stock consideration. The value of the per share cash election and the value of the per share stock election will be equalised ahead of closing such that the value of each election choice will be substantially the same. Merger Agreement Terminix Global Holdings, Inc. Investor Relations Rentokil Initial Investor Relations Termination Payment: Company Termination Payment (To be paid by Terminix Global Holdings): $200 million Parent Termination Payment (To be paid by Rentokil Initial): $150 million Update(s) March 15, 2022: Rentokil Initial and Terminix (TMX) announced that with effect from the close of business on 14 March 2022, the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 has now expired. May 9, 2022: Terminix Global Holdings (TMX) announced it has entered into a definitive agreement to divest its pest management businesses in the U.K. and Norway. These businesses are being divested by Terminix as a condition to the closing of its pending merger with Rentokil Initial (RTOKY).